The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.
暂无分享,去创建一个
K. Rezvani | K. Keyvanfar | A. Barrett | J. Goldman | B. Savani | A. Yong | R. Eniafe | Laura Musse | A. Shenoy | T. Donohue | E. Koklanaris | Q. Le